Amgen Inc. data breach

Clerk's notes

Amgen Inc., a major biotechnology company, filed a report with the Texas Attorney General on August 18, 2026, regarding a data security incident that occurred on July 1, 2026. The company has confirmed that an investigation into the nature and scope of this event is currently underway, impacting an unspecified number of individuals.

While the specific details of the breach type and the exact categories of information involved remain under investigation, data security incidents of this nature often lead to the unauthorized access or acquisition of personal information. For those affected, this can mean a loss of control over their private data, which was entrusted to Amgen Inc.

The exposure of personal information, even if specific types are not yet confirmed, creates potential risks for those whose data was involved. These risks can include identity theft, various forms of fraud, and other attempts to misuse personal details. Proactive steps are often necessary to help mitigate these potential harms.

If you have received an official data breach notification letter from Amgen Inc., it is important to carefully read and understand the information provided within it. This letter serves as formal confirmation that your personal data was impacted by this incident and may offer details about the company's response efforts.

Individuals who have been notified about the Amgen Inc. data breach may have legal options available to them. Consulting with a legal professional can help you understand these options and determine the best course of action for your particular circumstances. Our firm is currently reviewing potential claims on behalf of those affected by this incident.

If a notification letter about this breach reached you, see every Texas data breach on file or browse all cases.